{"abstract": "Pfizer said it \u201cdoes not intend to make an offer for AstraZeneca\u201d in the wake of AstraZeneca\u2019s rejection of a $119 billion bid.", "web_url": "https://dealbook.nytimes.com/2014/05/26/pfizers-says-its-bid-for-astrazeneca-is-dead/", "snippet": "Pfizer said it \u201cdoes not intend to make an offer for AstraZeneca\u201d in the wake of AstraZeneca\u2019s rejection of a $119 billion bid.", "lead_paragraph": "Updated, 9:36 p.m. | On the final day for Pfizer to decide whether to abandon the plan, it said it did not intend to make an offer for AstraZeneca. Last week, the British company rejected what Pfizer had called its final offer. The cash-and-stock bid, which valued AstraZeneca at about $119 billion, would have created the world\u2019s largest drug company.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/26/business/26dbpix-astrazeneca/26dbpix-astrazeneca-articleLarge.jpg", "height": 366, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/05/26/business/26dbpix-astrazeneca/26dbpix-astrazeneca-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 366}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/26/business/26dbpix-astrazeneca/26dbpix-astrazeneca-jumbo.jpg", "height": 625, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/26/business/26dbpix-astrazeneca/26dbpix-astrazeneca-superJumbo.jpg", "height": 1250, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/26/business/26dbpix-astrazeneca/26dbpix-astrazeneca-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/05/26/business/26dbpix-astrazeneca/26dbpix-astrazeneca-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/26/business/26dbpix-astrazeneca/26dbpix-astrazeneca-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Pfizer Abandons Bid for AstraZeneca", "kicker": "DealBook", "content_kicker": null, "print_headline": "Pfizer Abandons Bid for AstraZeneca", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "persons", "value": "Read, Ian C", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 5, "major": "N"}], "pub_date": "2014-05-26T14:39:52+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Jenny Anderson", "person": [{"firstname": "Jenny", "middlename": null, "lastname": "Anderson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/73fdd200-9ca2-5913-be04-69d619de876a", "word_count": 630, "uri": "nyt://article/73fdd200-9ca2-5913-be04-69d619de876a"}